TY - JOUR AU - Amaro, Sergio AU - Llull, Laura PY - 2016 TI - Preclinical randomized controlled multicenter trials in translational stroke research JF - Annals of Translational Medicine; Vol 4, Supplement 1 (October 31, 2016): Annals of Translational Medicine Y2 - 2016 KW - N2 - Natalizumab is a humanized monoclonal antibody against alpha-4 integrin (CD49d) that reduces the incursion of circulating leukocytes into the central nervous system across the endothelium (1). UR - https://atm.amegroups.org/article/view/12247